Contact

All Stories

  1. FORMULA‑Sigma: a reproducible, machine‑learning‑augmented workflow for pharmaceutical formulation design‑of‑experiments, with retrospective reproduction and analytical transparency

    Article • June 2026, American Chemical Society (ACS)

    Dr Salah Abdalrazak Alshehade

  2. Systematic Multi-Target QSAR Benchmarking: Machine Learning Algorithms, Molecular Descriptors, and Validation

    Article • Journal of Chemical Information and Modeling, June 2026, American Chemical Society (ACS)

    Dr Salah Abdalrazak Alshehade

  3. Exploring synergistic therapeutic potential of Erlotinib and artemisinin in non-small cell lung Cancer (NSCLC) using pharmacological networking and mathematical modeling

    Article • Clinica Chimica Acta, April 2026, Elsevier

    Dr Salah Abdalrazak Alshehade

  4. Factors Associated With CT Scan Repetition in Pediatrics and Its Relationship With Cancer Risk: A Systematic Review and Meta-Analysis

    Article • Dose-Response, April 2026, SAGE Publications

    Dr. Maisa Elzaki, Dr Salah Abdalrazak Alshehade

  5. Impact of diurnal versus nocturnal time-restricted eating on cardiometabolic health and circadian rhythm in healthy adults: A protocol for systematic review and meta-analysis

    Article • Nutrition and Health, February 2026, SAGE Publications

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  6. Computational and Data-Driven Approaches in Pharmaceutical Sciences: From Molecular Modelling to Evidence-Based Therapeutics

    Article • January 2026, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  7. Design and Development of Cyclodextrin Complex Reservoir in Fast–Dissolving Microneedles for Enhanced Transdermal Delivery of Paclitaxel

    Article • January 2026, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  8. Preparation & Characterisation of Free-Flowing Freeze-Dried Glibenclamide Microcapsules Using a Combination of Chitosan and Neusilin

    Article • January 2026, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  9. Structure-Based Design of Novel Farnesoid X Receptor Agonists for Non-Alcoholic Fatty Liver Disease Treatment

    Article • January 2026, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  10. The Efficacy and Safety Profile of Baxdrostat (CIN-107) in the Management of Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

    Article • January 2026, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  11. Biological Characterization of Mupirocin–KGF Hydrogel and Its Regenerative Potential in Human Fibroblast-Mediated Wound Healing

    Article • Molecules, November 2025, MDPI AG

    Dr Salah Abdalrazak Alshehade, Yeun-Mun Choo

  12. NeXus: An Automated Platform for Network Pharmacology and Multi-Method Enrichment Analysis

    Article • International Journal of Molecular Sciences, November 2025, MDPI AG

    Dr Salah Abdalrazak Alshehade

  13. Efficacy of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists in managing MALFD: a meta-analysis of randomized controlled trials

    Article • BMC Gastroenterology, October 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  14. AI in the Pharmaceutical Industry: A Shift in Drug Discovery, Development, and Delivery

    Article • October 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  15. Artificial Intelligence in Pharmaceutical Modelling

    Article • October 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  16. Ethical Considerations in the Application of Artificial Intelligence in the Pharmaceutical Industry

    Article • October 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  17. From Molecule to Market: The Role of AI in Shaping Modern Pharmacoeconomics

    Article • October 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  18. Wavelet-Enhanced Method Exploiting Wavelet Filters and SVD for Intelligent Clinical Image Processing

    Article • October 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  19. Introduction and Principles of Electrospraying and Electrospinning

    Article • September 2025, Taylor & Francis

    Dr Salah Abdalrazak Alshehade

  20. Bioinformatics mining and experimental validation of prognostic biomarkers in colorectal cancer

    Article • Discover Oncology, August 2025, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  21. Proteomic approaches for biomarker discovery and clinical applications in autoimmune diseases

    Article • Clinica Chimica Acta, August 2025, Elsevier

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  22. APPAS 1.0: An Automated Co-Polymer Polymerization and Analysis System: An Approach to Polymer Informatics

    Article • May 2025, MDPI AG

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  23. Review for "Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals"

    Article • May 2025, Wiley

    Dr Salah Abdalrazak Alshehade

  24. Comparison of the techniques for isolating immunoassay-suitable proteins from heterogeneous fecal samples

    Article • Analytical Biochemistry, March 2025, Elsevier

    Dr Salah Abdalrazak Alshehade

  25. Good Knowledge Influences the Junior and Senior Pharmacy Students to Self-Medicate

    Article • January 2025, Centivens Institute of Innovative Research

    Dr Salah Abdalrazak Alshehade

  26. Assessment of Osteoprotegerin and Receptor Activator of Nf-Kb Ligand in Malaysian Male Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

    Article • Revista de Investigación Clínica, November 2024, Elsevier

    Dr Salah Abdalrazak Alshehade

  27. Review for "Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis"

    Article • October 2024, Wiley

    Dr Salah Abdalrazak Alshehade

  28. Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics

    Article • Clinics and Research in Hepatology and Gastroenterology, August 2024, Elsevier

    Dr Salah Abdalrazak Alshehade

  29. Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: A protocol

    Article • Heliyon, July 2024, Elsevier

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  30. Elucidating the Impacts of Profitability on Economic Value Added: An Empirical Study of Pharmaceutical and Chemical Corporations in Jordan

    Article • Journal of Logistics Informatics and Service Science, May 2024, Success Culture Press

    Dr Salah Abdalrazak Alshehade

  31. Bioinformatics mining and experimental validation of prognostic biomarkers in colorectal cancer

    Article • April 2024, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade

  32. Terpenoids and Triterpenoid Saponins: Future Treatment for Depression

    Article • Current Traditional Medicine, April 2024, Bentham Science Publishers

    Dr Salah Abdalrazak Alshehade, Zaynab Mando

  33. CYP14 family in Caenorhabditis elegans: Mitochondrial function, detoxification, and lifespan

    Article • Journal of Applied Toxicology, March 2024, Wiley

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  34. Alginate-Based Encapsulation Fabrication Technique for Drug Delivery: An Updated Review of Particle Type, Formulation Technique, Pharmaceutical Ingredient, and Targeted Delivery System

    Article • Pharmaceutics, March 2024, MDPI AG

    Dr Salah Abdalrazak Alshehade

  35. Artificial intelligence applications and their impact on the qualitative characteristics of data: evidence from commercial banks

    Article • IET Conference Proceedings, January 2024, the Institution of Engineering and Technology (the IET)

    Dr Salah Abdalrazak Alshehade

  36. The Fabrication of Polymer-Based Curcumin-Loaded Formulation as a Drug Delivery System: An Updated Review from 2017 to the Present

    Article • Pharmaceutics, January 2024, MDPI AG

    Dr Salah Abdalrazak Alshehade

  37. The Impact of Sustainability Accounting on Financial Reporting Quality: Evidence from the Pharmaceutical and Chemical Sectors on the ASE

    Article • Journal of Logistics Informatics and Service Science, November 2023, Success Culture Press

    Dr Salah Abdalrazak Alshehade

  38. Factors Associated with CT-Scan Repetition among Pediatrics and its Relationship with Cancer Risk: A Systematic Review and Meta-Analysis Protocol

    Article • August 2023, Research Square

    Dr Salah Abdalrazak Alshehade, Dr. Maisa Elzaki

  39. Enhancing the Anti-Leukemic Potential of Thymoquinone/Sulfobutylether-β-cyclodextrin (SBE-β-CD) Inclusion Complexes

    Article • Biomedicines, July 2023, MDPI AG

    Dr Salah Abdalrazak Alshehade, Dr. Mohammed Abdullah Alshawsh

  40. Enhancing the Anti-Leukemic Potential of Thymoquinone- SBE-β-CD Inclusion Complex

    Article • June 2023, MDPI AG

    Dr Salah Abdalrazak Alshehade, Dr. Mohammed Abdullah Alshawsh

  41. Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications

    Article • Molecules, May 2023, MDPI AG

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  42. Orthosiphon aristatus (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic–Oleic Acid-Induced Steatosis in HepG2 Cells

    Article • Pharmaceuticals, January 2023, MDPI AG

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  43. The Chemotherapeutic Efficacy of Hyaluronic Acid Coated Polymeric Nanoparticles against Breast Cancer Metastasis in Female NCr-Nu/Nu Nude Mice

    Article • Polymers, January 2023, MDPI AG

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  44. Effect of monosodium glutamate on serum sex hormones and uterine histology in female rats along with its molecular docking and in-silico toxicity

    Article • Heliyon, October 2022, Elsevier

    Dr. Mohammed Abdullah Alshawsh, Dr Salah Abdalrazak Alshehade

  45. CYP35 family in Caenorhabditis elegans biological processes: fatty acid synthesis, xenobiotic metabolism, and stress responses

    Article • Archives of Toxicology, September 2022, Springer Science + Business Media

    Dr Salah Abdalrazak Alshehade, Dr. Mohammed Abdullah Alshawsh

  46. Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches

    Article • Saudi Pharmaceutical Journal, September 2022, Elsevier

    Dr Salah Abdalrazak Alshehade, Dr. Mohammed Abdullah Alshawsh

  47. The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions

    Article • Life Sciences, September 2022, Elsevier

    Dr Salah Abdalrazak Alshehade, Dr. Mohammed Abdullah Alshawsh

  48. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet

    Article • Molecules, January 2022, MDPI AG

    Dr Salah Abdalrazak Alshehade, Dr. Mohammed Abdullah Alshawsh

  49. Self-Medication Practice among Amman’s Householders: Prevalence and Factors

    Article • Journal of Pharmaceutical Research International, July 2020, Sciencedomain International

    Dr Salah Abdalrazak Alshehade